52 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
PACB Pacific Biosciences of California, Inc. $5.14 $678.18M N/A
Article Searches
3 Big Reasons to Be Bullish on Biotech Stocks https://www.fool.com/investing/2017/04/16/3-big-reasons-to-be-bullish-on-biotech-stocks.aspx?source=iedfolrf0000001 Apr 16, 2017 - Have you shied away from investing in the biotech sector? Here are three key reasons why you may want to reconsider that decision.
The Top Gene-Sequencing Stock to Buy in 2017 https://www.fool.com/investing/2017/04/20/the-top-gene-sequencing-stock-to-buy-in-2017.aspx?source=iedfolrf0000001 Apr 20, 2017 - Illumina is investors' best buy in this category.
The Two Reasons Why Illumina Rose 8.3% In April https://www.fool.com/investing/2017/05/10/why-illumina-rose-83-in-april.aspx?source=iedfolrf0000001 May 10, 2017 - A new product launch and upbeat first-quarter results caused Illumina's stock to rally.
This Is the Big Reason Behind Pacific Biosciences of California, Inc.'s 24% Tumble in April https://www.fool.com/investing/2017/05/03/this-is-the-big-reason-behind-pacific-biosciences.aspx?source=iedfolrf0000001 May 03, 2017 - Despite topping Q1 revenue estimates, another figure in Pacific Biosciences quarterly report doomed its stock.
Pacific Biosciences of California (PACB) Presents At Photonics Summit and Workshop - Slideshow https://seekingalpha.com/article/4104472-pacific-biosciences-california-pacb-presents-photonics-summit-workshop-slideshow?source=feed_all_articles Sep 06, 2017 - The following slide deck was published by Pacific Biosciences of California in conjunction with this event.
Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3966903-pacific-biosciences-californias-pacb-ceo-mike-hunkapiller-q1-2016-results-earnings-call?source=feed_all_articles Apr 22, 2016 - Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2016 Earnings Conference Call April 21, 2016 04:30 PM ET Executives Trevin Rard - IR Mike Hunkapiller - CEO Susan Barnes - CFO Ben Gong - VP of
Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3996134-pacific-biosciences-californias-pacb-ceo-mike-hunkapiller-q1-2016-results-earnings-call?source=feed_sector_healthcare Aug 05, 2016 - Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2016 Earnings Conference Call August 4, 2016 04:30 PM ET Executives Trevin Rard - IR Mike Hunkapiller - CEO Susan Barnes - CFO Ben Gong - VP, F
Pacific Biosciences (PACB) Q1 Loss Wider than Estimated http://www.zacks.com/stock/news/258121/pacific-biosciences-pacb-q1-loss-wider-than-estimated?cid=CS-ZC-FT-258121 Apr 27, 2017 - Pacific Biosciences of California Inc. (PACB) reported a loss of 26 cents per share in the first quarter of 2017. The figure is 3 cents wider than the Zacks Consensus Estimate.
Here's Why Pacific Biosciences of California Is Surging Today https://www.fool.com/investing/2017/08/03/heres-why-pacific-biosciences-of-california-is-sur.aspx?source=iedfolrf0000001 Aug 03, 2017 - The sequencing company topped off a solid second-quarter earnings report with news of a big order from its best customer.
Pacific Biosciences of California Struggles in the Second Quarter With Lower Sales https://www.fool.com/investing/2017/08/03/pacific-biosciences-of-california-struggles-in-sec.aspx?source=iedfolrf0000001 Aug 03, 2017 - The genetic-sequencing company's lone bright spot was higher product sales, but it wasn't enough to offset the loss of contract revenue.

Pages: 123456

Page 1>